No CrossRef data available.
Article contents
Síntomas extrapiramidales graves con fluvoxamina a pesar de la supresión de neurolépticos
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS1134066500002186/resource/name/firstPage-S1134066500002186a.jpg)
- Type
- Carta al director
- Information
- Copyright
- Copyright © European Psychiatric Association 1997
References
Bibliografia
Arya, DExtrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 1994; 165: 728–33.CrossRefGoogle ScholarPubMed
Coulter, DPillans, PFluoxetine and extrapyramidal side effects. Am J Psychiatry 1995; 152: 122–5.Google ScholarPubMed
Crewe, HLennard, MTucker, GWoods, FHaddock, RThe effects of selective serotonine reuptake inhibitors on cytochrome P4502D6 activity in human liver microsomes. Br J Clin Pharmacol 1992; 34: 262–5.CrossRefGoogle Scholar
Wils, VExtrapyramidal symptoms in a patient treated with fluvoxamine. J Neurol Neurosurg Psychiatry 1992; 55: 330–1.CrossRefGoogle Scholar